BIOQUAL, Inc.
BIOQUAL provides preclinical research services supporting infectious disease, oncology and immunogenicity programs. Services include in vivo studies in small and large animals (including non-human primates), in vitro assay development and execution, BSL-3 biocontainment operations, imaging, custom animal-model development, and IND‑enabling toxicology and PK/PD studies. Facilities are AAALAC‑accredited and registered with relevant U.S. oversight bodies.
Industries
N/A
Services
In vivo preclinical studies
End‑to‑end in vivo studies in small and large animals including study design, execution, dosing (multiple routes), and data collection for vaccine and therapeutic development.
In vitro lab services
Cell‑based assays, immunoassays, viral‑load testing, cytotoxicity/toxicity assays and custom assay development for preclinical programs.
Advanced biocontainment (BSL‑3) services
Access to BSL‑3 facilities and personnel qualified to conduct research on high‑risk pathogens under select‑agent standards.
Animal model development
Design and creation of reproducible, translational animal models including transgenic, knockout, humanized and disease‑specific models.
IND‑enabling and GLP support
Toxicology, pharmacokinetics, safety studies and regulatory documentation to support IND submissions.
Preclinical imaging services
Imaging to assess mechanism of action, biodistribution and therapeutic efficacy in preclinical studies.
In vivo preclinical studies
End‑to‑end in vivo studies in small and large animals including study design, execution, dosing (multiple routes), and data collection for vaccine and therapeutic development.
In vitro lab services
Cell‑based assays, immunoassays, viral‑load testing, cytotoxicity/toxicity assays and custom assay development for preclinical programs.
Advanced biocontainment (BSL‑3) services
Access to BSL‑3 facilities and personnel qualified to conduct research on high‑risk pathogens under select‑agent standards.
Animal model development
Design and creation of reproducible, translational animal models including transgenic, knockout, humanized and disease‑specific models.
IND‑enabling and GLP support
Toxicology, pharmacokinetics, safety studies and regulatory documentation to support IND submissions.
Preclinical imaging services
Imaging to assess mechanism of action, biodistribution and therapeutic efficacy in preclinical studies.
Expertise Areas
- Preclinical study design and execution
- Animal model development (small and large animals, NHP)
- Virology and vaccine testing
- Immunogenicity and immune profiling
Key Technologies
- BSL‑3 biocontainment
- Non‑human primate models
- Transgenic/knockout/humanized and xenograft models
- qRT‑PCR / RT‑PCR